Photo: Video_Creative/Shutterstock.com
U.K.-based Mallinckrodt is the first company charged in a broader DFS investigation into the opioid crisis, according to the agency.
April 21, 2020 at 05:19 PM
1 minute read
The original version of this story was published on New York Law Journal
The New York State Department of Financial Services has charged the drug manufacturer Mallinckrodt with fraudulent insurance acts and intentional misrepresentation of facts, arguing that the company contributed to the opioid crisis in the United States by downplaying the risks and overstating the benefits of long-term opioid use.
U.K.-based Mallinckrodt is the first company charged in a broader DFS investigation into the opioid crisis, according to the agency.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
